Summary
Overview
Work History
Education
Skills
Certification
Qualifications
Languages
Timeline
Generic

Michelle Ramage

Greenwood,IN

Summary

Experienced with clinical trial management, ensuring seamless progression from start to finish. Utilizes strategic planning and regulatory acumen to uphold compliance and project integrity. Track record of fostering effective team collaboration and achieving reliable outcomes.

Overview

21
21
years of professional experience
1
1
Certification

Work History

Sr. Clinical Research Associate I

Syneos Health (previously INC. Research)
2021.02 - Current
  • IM011-1069 A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults with Active Sjogren's Syndrome (POETYK SjS-1)
  • AKST4290-231 A double-masked, placebo-controlled study to evaluate the efficacy of oral AKST 4290 in participants with moderately severe to severe diabetic retinopathy
  • CSOK583A12301 A 52-week multicenter, randomized, double-masked, 2-arm parallel study to compare efficacy, safety and immunogenicity of SOK583A1 to Eylea, administered intravitreally, in patients with neovascular age-related macular degeneration

Sr. Clinical Research Associate I

TFS Trial Form Support, Inc., USA
2019.12 - 2021.02
  • CLOSE-1/ CLOSE 2 CLOBOF3-16IA01/ CLOBOF3-16IA02 A phase 3, multicenter, randomized, double-masked clinical trial to assess the efficacy and safety of clobetasol propionate ophthalmic nano emulsion 0.05% compared to placebo in the treatment of inflammation and pain associated with cataract surgery
  • Elite Site Network Initiative Team- Development of a select network of proven sites, to provide therapeutic experience input, quality and boost enrollment for sponsors.

Clinical Research Associate

Syneos Health (previously INC. Research)
2016.10 - 2019.02
  • CLS 1003-301 A randomized, masked, controlled trial to study the safety and efficacy of Suprachoroidal CLS-TA in conjunction with Intravitreal Aflibercept in subjects with retinal vein occlusion.
  • KHB-1801 and KHB-1802 A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration.
  • 696844-CS5 A Phase 2, randomized, placebo-controlled, double-masked study to assess safety and efficacy of multiple doses of IONIS-FB-LRX, an antisense inhibitor of Complement Factor B, in patients with geographic atrophy secondary to age-related Macular Degeneration (AMD).
  • NGF0118 A 4 week, Phase II, multicenter, randomized, double-masked, vehicle-controlled, parallel group study with 12 weeks of follow-up to evaluate safety and efficacy of recombinant human Nerve Growth Factor (rhNGF) eye drops solution versus vehicle in patients with moderate to severe dry eye (DE).

Ophthalmic Clinical Trials Study Staff

Cornea Research Foundation of America
2008.08 - 2016.10
  • Prospective, randomized comparison of corticosteroid dosing regimens following endothelial keratoplasty. Cornea Research Foundation of America 2013/Active.
  • Prospective study of the incidence of graft rejection episodes and intraocular pressure elevation in the second year after Descemet membrane endothelial keratoplasty. Cornea Research Foundation of America 2012/Active.
  • A Prospective Evaluation of Treatment Duration of the UVXTM System for treating infectious keratitis. Cornea Research Foundation of America. 2009/Active.
  • Efficacy and safety of bromfenac ophthalmic solution QD vs. placebo QD for treatment of ocular inflammation and pain associated with cataract surgery. ISTA Pharmaceuticals, Inc. 2009.
  • Open-enrollment, prospective study of endothelial keratoplasty outcomes. Cornea Research Foundation of America – 2008/ongoing.
  • A prospective multi-center clinical study to evaluate the safety and effectiveness of the light adjustable lens (LAL) in subjects undergoing cataract extraction. Calhoun Vision, Inc. 2009/Completed.
  • FECD Genetics Multi-Center Study. Case Vision Research Coordinating Center – 2006/ongoing.

Ophthalmic Clinical Trials Study Staff

Midwest Eye Institute
2005.01 - 2008.07
  • Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema Diabetic Retinopathy Clinical Research Network Ophthalmology, Vol. 114, Issue 10, p1860–1867.e7
  • Randomized trial evaluating Ranibizumab plus prompt or deferred laser or Triamcinolone plus prompt laser for Diabetic Macular Edema. The Diabetic Retinopathy Clinical Research Network Ophthalmology, Vol. 117, Issue 6, p1064–1077.e35
  • Vitrectomy Outcomes in Eyes with Diabetic Macular Edema and Vitreomacular Traction Diabetic Retinopathy Clinical Research Network Writing Committee on behalf of the DRCR.net Ophthalmology, Vol. 117, Issue 6, p1087–1093.e3
  • A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema Diabetic Retinopathy Clinical Research Network Ophthalmology, Vol. 115, Issue 9, p1447–1459.e10
  • A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone with observation to treat vision loss associated with Macular Edema secondary to central retinal vein occlusion. The SCORE study research group Arch Ophthalmol. 2009; 127(9):1101-1114. doi:10.1001/archophthalmol.2009.234.

Education

Nursing -

Miami University of Ohio
Middletown, OH

Skills

  • Data management proficiency
  • Coordinating site operations
  • Informed consent process
  • Adverse event reporting
  • Quality assurance techniques
  • Clinical trial management
  • Vendor management experience
  • Completing regulatory documents
  • Site management
  • Investigator relations
  • Medical terminology fluency
  • ICH-gCP guidelines
  • Patient recruitment strategies
  • Electronic data capture systems
  • Good clinical practices
  • Patient recruitment
  • Documentation requirements
  • Excellent communication
  • Medical terminology

Certification

JCAHPO Certification, COA

Qualifications

  • CRA professional with more than 20 years of clinical Ophthalmology experience and more than 14 years as a Clinical Research Assistant/BCVA examiner. Active participation in Phase II & III ophthalmology studies with a concentration in diabetic macular edema, Retinal vein occlusion, exudative macular degeneration, Fuchs’s dystrophy, cornea crosslinking for keratoconus and infectious keratitis, as well as dry eye studies. Device trial experience includes implantable artificial iris for aniridia and light adjustable intraocular lens.
  • Experience in site identification/feasibility and study start up processes.
  • Maintain timely and effective communication among team members and site staff. Anticipates, identifies and resolves issues impacting the study.
  • Ensures compliance with local regulations, Code of federal Regulations (CFR), International Conference of Harmonization (ICH) according to essential Regulatory Document Guidelines Trial Master File (TMF) plan. Participates in TMF and on-site audits as requested.
  • Responsible for site management and site staff performance.
  • Participate in all types of site visits ensuring compliance with protocol requirements, patient identification and recruitment plan is in place, and timely reporting of Adverse Effects (AE’s) / Serious Adverse Effects (SAE’s) and protocol violations.
  • Ensures proper storage, and accountability of all Investigational products and trial related materials.
  • Reviews the site regulatory binder for accuracy.
  • Completes and submits Case Report Forms according to Clinical Monitoring Plan and/or Data Management Plan. Assures timely and accurate completion of Data Clarification Forms.
  • Complete/submit visit reports according to SOP/Work Instructions (WI) requirements. Monitor key study performance indicators such as Telephone Communications Reports, patient enrollment, and SAEs.
  • Document and track resolution of all outstanding site-specific protocol-related issues from visit to visit.
  • Prepares for and attends Investigator meetings. Assists with the preparation of study start up materials and tools. Participates in clinical monitoring staff meetings, project team meetings, and clinical training sessions according to the project communication, monitoring, and/or training plans.

Languages

English

Timeline

Sr. Clinical Research Associate I

Syneos Health (previously INC. Research)
2021.02 - Current

Sr. Clinical Research Associate I

TFS Trial Form Support, Inc., USA
2019.12 - 2021.02

Clinical Research Associate

Syneos Health (previously INC. Research)
2016.10 - 2019.02

Ophthalmic Clinical Trials Study Staff

Cornea Research Foundation of America
2008.08 - 2016.10

Ophthalmic Clinical Trials Study Staff

Midwest Eye Institute
2005.01 - 2008.07

Nursing -

Miami University of Ohio
Michelle Ramage